Akèy › Tit travay › Scientist
Scientist: Salè H-1B
1,232 aplikasyon kondisyon travay te itilize tit travay Scientist. Salè baz medyàn ofri $100,000; mwatye mitan $85,342–$124,499.
Demann (LCA)1,232
Salè medyan ofri$100,000
Mwatye salè yo$85,342–$124,499
10yèm–90yèm pousantaj$73,830–$140,213
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| St. Jude Children's Research Hospital | 138 | $86,320 |
| Frontage Laboratories, Inc. | 52 | $73,282 |
| Children's Hospital Corporation | 42 | $90,000 |
| Genentech, Inc. | 33 | $126,960 |
| Bristol-Myers Squibb Company | 31 | $125,824 |
| The Curators of the University of Missouri | 28 | $56,368 |
| Kelly Services, Inc. | 26 | $96,907 |
| California Institute of Technology/Jet Propulsion Laboratory | 26 | $139,046 |
| Amgen Inc. | 26 | $135,000 |
| Takeda Development Center Americas, Inc. | 24 | $125,000 |
| The Henry M. Jackson Foundation | 22 | $73,800 |
| Regeneron Pharmaceuticals, Inc. | 19 | $116,358 |
| Axle Informatics LLC | 16 | $99,800 |
| Dana-Farber Cancer Institute | 15 | $90,000 |
| Michigan State University | 15 | $99,304 |
| Triad National Security, LLC | 14 | $128,000 |
| Sanofi US Services Inc. | 14 | $99,422 |
| Intellia Therapeutics | 13 | $133,150 |
| Alnylam US, Inc. | 12 | $126,000 |
| The J. David Gladstone Institutes | 11 | $76,515 |
| GAP Solutions Inc. | 11 | $140,454 |
| University of Rochester | 10 | $98,000 |
| New York Structural Biology Center | 10 | $113,400 |
| Sana Biotechnology, Inc. | 10 | $135,000 |
| Uber Technologies, Inc. | 10 | $161,400 |
| The Children's Hospital of Philadelphia | 8 | $59,998 |
| Arcus Biosciences, Inc. | 8 | $125,000 |
| AstraZeneca Pharmaceuticals LP | 8 | $102,298 |
| University of Miami | 8 | $117,010 |
| Children's Hospital Pediatric Associates, Inc. | 8 | $96,523 |
| Honda Research Institute USA, Inc. | 7 | $140,067 |
| Calico Life Sciences LLC | 7 | $156,000 |
| CZ Biohub SF, LLC | 6 | $112,500 |
| Astrix Technology, LLC | 6 | $100,000 |
| Guardant Health, Inc. | 6 | $137,280 |
| Primera Analytical Solutions Corporation | 6 | $78,052 |
| Mylan Pharmaceuticals, Inc. | 6 | $86,320 |
| Corixa Corporation | 6 | $96,484 |
| Pfizer Inc. | 5 | $88,962 |
| Arc Research Institute | 5 | $125,000 |
| Evotec (US), Inc. | 5 | $85,099 |
| Nestle R&D Center, Inc | 5 | $92,040 |
| Infor (US), LLC | 5 | $118,000 |
| Denali Therapeutics Inc. | 5 | $125,876 |
| Amyris, Inc. | 5 | $145,484 |
| Bayer Research and Development Services LLC | 5 | $97,708 |
| Guidehouse Digital LLC | 4 | $89,000 |
| Impossible Foods Inc. | 4 | $119,278 |
| MedImmune LLC | 4 | $85,344 |
| Slingshot Biosciences, Inc. | 4 | $130,500 |
| Sanofi Pasteur Inc. | 4 | $106,278 |
| PPD Development, L.P. | 4 | $62,078 |
| Lonza Walkersville, Inc. | 4 | $104,538 |
| Takara Bio USA Inc. | 4 | $145,600 |
| Im Pro Makeup Ny LP | 4 | $150,000 |
| Eli Lilly and Company | 4 | $74,865 |
| A-New Bio Inc | 4 | $108,000 |
| Southern California Coastal Water Research Project | 3 | $93,201 |
| General Dynamics Information Technology, Inc. | 3 | $84,178 |
| Signify North America Corporation | 3 | $153,600 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $79,331 |
| Nivo II (kalifye) | $97,000 |
| Nivo III (eksperyans) | $121,928 |
| Nivo IV (plen kompetans) | $130,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 341 | $96,242 |
| FY2024 | 273 | $104,000 |
| FY2025 | 326 | $100,000 |
| FY2026 | 244 | $105,000 |
Vil yo
- Memphis, TN140
- Cambridge, MA82
- Boston, MA80
- South San Francisco, CA78
- Bethesda, MD61
- Exton, PA50
- San Francisco, CA30
- New York, NY29
- Columbia, MO28
- Pasadena, CA25
- Gaithersburg, MD24
- San Diego, CA23
- Waltham, MA20
- Tarrytown, NY18
- San Jose, CA17
- Lexington, MA15
- Redwood City, CA15
- Palo Alto, CA15
- East Lansing, MI15
- Emeryville, CA15
- Philadelphia, PA14
- Los Alamos, NM13
- Princeton, NJ13
- New Brunswick, NJ13
- Rockville, MD12
- Thousand Oaks, CA12
- Rochester, NY10
- Seattle, WA9
- Durham, NC9
- Hayward, CA9
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).